A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs
OMEGAZEPRIME News
This story was selected and curated by our editorial team in the Cancer category. Published on August 31, 2026 • Originally reported by Rebecca Robbins. OMEGAZEPRIME provides independent news coverage and analysis for our readers. Stay informed with the latest developments.
Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices over the past two decades.
This story was selected and curated by our editorial team in the Cancer category. Published on August 31, 2026 • Originally reported by Rebecca Robbins. OMEGAZEPRIME provides independent news coverage and analysis for our readers. Stay informed with the latest developments.
OMEGAZEPRIME News — For more stories and analysis, visit omegazeprime.com